Dr Stephen Hoffman | Chief Executive and Scientific Officer
Sanaria Inc

Dr. Hoffman is the Founder (2002), and Chief Executive and Scientific Officer of Sanaria Inc., a company dedicated to developing a whole sporozoite malaria vaccine. From 1987-2001 he was Director of the Malaria Program at the Naval Medical Research Center where he and his team were leaders in the sequencing of the Plasmodium falciparum genome and conducted the first studies in the world that showed that DNA vaccines elicited killer T cells in humans. In 2001 he joined Celera Genomics as Senior Vice President of Biologics where he created a program to utilize genomics and proteomics to produce biopharmaceuticals, and organized sequencing of the genome of the mosquito, Anopheles gambiae. He has held several professorships, and chairs or serves on multiple advisory boards, is a past president of the American Society of Tropical Medicine and Hygiene, authored more than 375 scientific publications, and has numerous patents. He is the most highly cited author in the world for scientific papers on malaria published between 1995 and 2005. He received his B.A. from the University of Pennsylvania, M.D. from Cornell, and Diploma in Tropical Medicine and Hygiene from the London School of Hygiene and Tropical Medicine, did residency training at UC San Diego, and is a member of the Institute of Medicine of the National Academies.